Mixed reactions among HCPs as lecanemab and donanemab secure FDA approval for Alzheimer's treatment

Pharmaphorum is an online publication on a mission to educate, inform, engage, and connect pharmaceutical industry leaders and to equip them to thrive in healthcare’s evolving digital future.